Professor Henrik Zetterberg
Professor of Neurochemistry, Senior Consultant in Clinical Chemistry, Head of Department
Place of work / study:
The Sahlgrenska Academy at the University of Gothenburg, Sweden, and University College London, UK.
Area of Research:
Fluid biomarkers for neurodegenerative dementias.
Tell us a little about yourself:
I studied medicine because I wanted to engage in science. My first aim was to become a virologist, inspired by the molecular work on viral oncogenesis that was prominent during the late 1980s, but also by the prion field. I did my thesis on transcriptional regulation in Epstein-Barr virus-induced lymphoproliferative disease. During my clinical specialisation in Clinical Chemistry, I met Kaj Blennow who taught me neurochemistry which then became my scientific field. Occasionally, I study virus effects on the brain (HIV, herpes and now also corona).
Tell us a fun fact about yourself:
Since 2015, I write a column in Göteborgs-Posten (the Gothenburg Post; the biggest newspaper in western Sweden; almost as prestigious as the Washington Post).
Why did you choose to work in dementia?
Serendipity, I think, but at the same time clinical chemistry tests for neurodegenerative dementias were just emerging when I started my clinical specialisation, and I found those highly interesting and had a gut feeling that it would turn out interesting to engage in that work.